We are upgrading the repository! A content freeze is in effect until December 6, 2024. New submissions or changes to existing items will not be allowed during this period. All content already published will remain publicly available for searching and downloading. Updates will be posted in the Website Upgrade 2024 FAQ in the sidebar Help menu. Reach out to escholarship@umassmed.edu with any questions.
Longterm Effectiveness of Intraarticular Injections on Patient-reported Symptoms in Knee Osteoarthritis
Authors
Liu, Shao-HsienDube, Catherine E
Eaton, Charles B.
Driban, Jeffrey B.
McAlindon, Timothy E.
Lapane, Kate L
UMass Chan Affiliations
Division of Epidemiology of Chronic Diseases and Vulnerable Populations, Department of Quantitative Health SciencesDocument Type
Journal ArticlePublication Date
2018-06-15Keywords
EpidemiologyHealth Services Administration
Health Services Research
Hormones, Hormone Substitutes, and Hormone Antagonists
Musculoskeletal Diseases
Rheumatology
Therapeutics
Metadata
Show full item recordAbstract
OBJECTIVE: We examined the longterm effectiveness of corticosteroid or hyaluronic acid injections in relieving symptoms among persons with knee osteoarthritis (OA). METHODS: Using Osteoarthritis Initiative data, a new-user design was applied to identify participants initiating corticosteroid or hyaluronic acid injections (n = 412). Knee symptoms (pain, stiffness, function) were measured using The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). We used marginal structural models adjusting for time-varying confounders to estimate the effect on symptoms of newly initiated injection use compared to nonusers over 2 years of followup. RESULTS: Among 412 participants initiating injections, 77.2% used corticosteroid injections and 22.8% used hyaluronic acid injections. About 18.9% had additional injection use after initiation, but switching between injection types was common. Compared to nonusers, on average, participants initiating a corticosteroid injection experienced a worsening of pain (yearly worsening: 1.24 points, 95% CI 0.82-1.66), stiffness (yearly worsening: 0.30 points, 95% CI 0.10-0.49), and physical functioning (yearly worsening: 2.62 points, 95% CI 0.94-4.29) after adjusting for potential confounders with marginal structural models. Participants initiating hyaluronic acid injections did not show improvements of WOMAC subscales (pain: 0.50, 95% CI -0.11 to 1.11; stiffness: -0.07, 95% CI -0.38 to 0.24; and functioning: 0.49, 95% CI -1.34 to 2.32). CONCLUSION: Although intraarticular injections may support the effectiveness of reducing symptoms in short-term clinical trials, the initiation of corticosteroid or hyaluronic acid injections did not appear to provide sustained symptom relief over 2 years of followup for persons with knee OA.Source
J Rheumatol. 2018 Jun 15. pii: jrheum.171385. doi: 10.3899/jrheum.171385. [Epub ahead of print] Link to article on publisher's site
DOI
10.3899/jrheum.171385Permanent Link to this Item
http://hdl.handle.net/20.500.14038/46744PubMed ID
29907665Related Resources
ae974a485f413a2113503eed53cd6c53
10.3899/jrheum.171385